Search Ontology:
ChEBI

N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine

Term ID
CHEBI:50670
Synonyms
  • 2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
  • 2-acetamido-4-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-beta-D-glucopyranose
  • beta-D-GlcNAc-(1->4)-beta-D-GlcNAc
  • beta-D-GlcpNAc-(1->4)-beta-D-GlcpNAc
  • beta-di-N-acetylchitobiose
  • betaGlcNAc(1->4)betaGlcNAc
  • DI(N-ACETYL-D-GLUCOSAMINE)
  • GlcNAcb1-4GlcNAcb
  • GlcNAcbeta1-4GlcNAcbeta
  • N,N'-diacetylchitobiose
Definition
An N,N'-diacetylchitobiose having β-configuration at the reducing end anomeric centre.
References
  • drugbank:DB03013
  • glygen:G42666HT
  • glytoucan:G42666HT
  • patent:US7060790
  • pdb-ccd:CBS
  • pubmed:12617608
  • pubmed:18083153
  • pubmed:19059777
  • pubmed:19443021
  • pubmed:20045674
  • pubmed:31537530
  • pubmed:32568414
  • pubmed:36988069
  • pubmed:7521740
  • reaxys:1443242
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine
Phenotype where environments contain N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine
Phenotype modified by environments containing N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine
Phenotype affecting N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine
Human Disease Model